| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.2 | 0.0005 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.054 | 0.4 |